Abstract
The prevalence of somatic insulinopathies, like metabolic syndrome (MetS), obesity, and type 2 diabetes mellitus (T2DM), is higher in Alzheimer’s disease (AD), autism spectrum disorder (ASD), and obsessive-compulsive disorder (OCD). Dysregulation of insulin signalling has been implicated in these neuropsychiatric disorders, and shared genetic factors might partly underlie this observed multimorbidity. We investigated the genetic overlap between AD, ASD, and OCD with MetS, obesity, and T2DM by estimating pairwise global genetic correlations using the summary statistics of the largest available genome-wide association studies for these phenotypes. Having tested these hypotheses, other potential brain “insulinopathies” were also explored by estimating the genetic relationship of six additional neuropsychiatric disorders with nine insulin-related diseases/traits. Stratified covariance analyses were then performed to investigate the contribution of insulin-related gene sets. Significant negative genetic correlations were found between OCD and MetS (rg = −0.315, p = 3.9 × 10−8), OCD and obesity (rg = −0.379, p = 3.4 × 10−5), and OCD and T2DM (rg = −0.172, p = 3 × 10−4). Significant genetic correlations with insulin-related phenotypes were also found for anorexia nervosa (AN), attention-deficit/hyperactivity disorder (ADHD), major depressive disorder, and schizophrenia (p < 6.17 × 10−4). Stratified analyses showed negative genetic covariances between AD, ASD, OCD, ADHD, AN, bipolar disorder, schizophrenia and somatic insulinopathies through gene sets related to insulin signalling and insulin receptor recycling, and positive genetic covariances between AN and T2DM, as well as ADHD and MetS through gene sets related to insulin processing/secretion (p < 2.06 × 10−4). Overall, our findings suggest the existence of two clusters of neuropsychiatric disorders, in which the genetics of insulin-related diseases/traits may exert divergent pleiotropic effects. These results represent a starting point for a new research line on “insulinopathies” of the brain.
Highlights
Mental disorders are characterised by a reduced life expectancy of ~10 years [1]
In light of the above evidence, we aimed to investigate the extent of the potential genetic sharing and contribution of insulinrelated gene sets in the observed comorbidity of neuropsychiatric disorders having preclinical evidence of insulin signalling dysregulation (i.e., Alzheimer’s disease (AD), autism spectrum disorder (ASD), and obsessive-compulsive disorder (OCD)) with somatic diseases related to insulin resistance, namely metabolic syndrome (MetS), obesity, and type 2 diabetes mellitus (T2DM)
In this study, we investigated the genetic overlap of AD, ASD, OCD with somatic insulinopathies, namely MetS, obesity and T2DM, hypothesising an important role for gene sets related to insulin signalling
Summary
Mental disorders are characterised by a reduced life expectancy of ~10 years [1]. In addition to violent causes of death, more than 67% of the increase in premature mortality is due to natural causes [2]. The increased prevalence of insulin-related somatic diseases (i.e., type 2 diabetes mellitus (T2DM), obesity, and metabolic syndrome (MetS)) observed in mental disorders, with a resulting increased cardiovascular risk, contributes significantly to the lower life expectancy [3]. A number of studies have investigated this higher comorbidity, focusing mainly on metabolic disturbances as possible consequences of unhealthy lifestyles, sedentary habits, or the chronic use of psychotropic medication [4]. Shared genetic factors may play a role, and genomic studies may help to unravel the biological underpinnings of the phenotypically observed comorbidity of neuropsychiatric disorders with somatic insulin-related diseases and traits
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
